Table 5.
Clinical Research Sample Test Results
| Samples (n) | Anti-parvovirus B19 serology
|
Parvovirus B19 DNA
|
||
|---|---|---|---|---|
| IgG | IgM | NAT system 1 | NAT system 2 | |
| 15 | −ve | −ve | −ve | −ve |
| 35 | +ve | −ve | −ve | −ve |
| 1 | +ve | −ve | +ve | −ve |
| 4 | +ve | +ve | −ve | −ve |
| 4 | +ve | +ve | −ve | +ve |
| 51 | +ve | +ve | +ve | +ve |
Clinical research samples were processed and analysed according to the workflow as described in the Material and Methods section. (NAT system 1: in-house reference method; NAT system 2: TNAI Kit on COBAS AmpliPrep instrument with LightCycler Parvovirus B19 Quantification Kit).